Brief: GlaxoSmithKline Pharma Sells Vemgal Manufacturing Facility To Hetero Labs
March 31 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd
GLAX.NS :
* SAYS SALE OF COMPANY''S MANUFACTURING FACILITY LOCATED AT
VEMGAL, KARNATAKA
* DEAL FOR 1.80 BILLION RUPEES
* BUYER OF MANUFACTURING FACILITY IS HETERO LABS LTD
Source text for Eikon: ID:nBSE5lNZ5t
Further company coverage: GLAX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees